{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:33:10Z","timestamp":1784802790011,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejrad.2019.06.017","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T17:02:50Z","timestamp":1561136570000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance"],"prefix":"10.1016","volume":"118","author":[{"given":"Woo Jung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-1074","authenticated-orcid":false,"given":"Hee Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-1570","authenticated-orcid":false,"given":"Ga Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2019.06.017_bib0005","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"Mieog","year":"2007","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0010","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.2007.15.3510","article-title":"Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease","volume":"26","author":"Gralow","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0015","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006","volume":"18","author":"Kaufmann","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0020","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1200\/JCO.2003.05.208","article-title":"Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?","volume":"21","author":"Ring","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/bjs.9545","article-title":"Surgical treatment of primary breast cancer in the neoadjuvant setting","volume":"101","author":"Kummel","year":"2014","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27","volume":"26","author":"Rastogi","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0035","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0040","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.ejca.2011.06.014","article-title":"Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients","volume":"47","author":"Kong","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0045","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: translational breast cancer research consortium trial 017","volume":"119","author":"De Los Santos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/djs528","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"105","author":"Marinovich","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2214\/AJR.09.3908","article-title":"Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysis","volume":"195","author":"Yuan","year":"2010","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0065","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clbc.2017.08.003","article-title":"Evaluation of the tumor response after neoadjuvant chemotherapy in breast cancer patients: correlation between dynamic contrast-enhanced magnetic resonance imaging and pathologic tumor cellularity","volume":"18","author":"Choi","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.02.008","article-title":"Pretreatment MRI features associated with diagnostic accuracy of post-treatment MRI after neoadjuvant chemotherapy","volume":"73","author":"Eun","year":"2018","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/0284185114538622","article-title":"Effective factors to raise diagnostic performance of breast MRI for diagnosing pathologic complete response in breast cancer patients after neoadjuvant chemotherapy","volume":"56","author":"Choi","year":"2015","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","article-title":"The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review","volume":"4","author":"Lobbes","year":"2013","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0085","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","article-title":"Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised?","volume":"24","author":"Feliciano","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/bjc.2015.381","article-title":"Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques","volume":"113","author":"Heil","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2016.09.034","article-title":"Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?","volume":"69","author":"Heil","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0100","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-018-6481-y","article-title":"Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: imaging assessment and correlation endpoints","volume":"25","author":"Rauch","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0105","doi-asserted-by":"crossref","first-page":"20140142","DOI":"10.1259\/bjr.20140142","article-title":"Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection","volume":"87","author":"Kim","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.2441060634","article-title":"Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions","volume":"244","author":"Williams","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0115","series-title":"ACR BI-RADS Atlas Breast Imaging and Reporting Data System","author":"American College of Radiology, BI-RADS Committee","year":"2013"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0120","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0125","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/GCO.0b013e32835c0889","article-title":"Update on neoadjuvant\/preoperative therapy of breast cancer: experiences from the German breast group","volume":"25","author":"von Minckwitz","year":"2013","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-016-0684-6","article-title":"Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials","volume":"18","author":"van la Parra","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1245\/s10434-014-4113-8","article-title":"Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer","volume":"22","author":"Adrada","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12957-017-1263-8","article-title":"Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor","volume":"15","author":"An","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.198.2.8596827","article-title":"Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation","volume":"198","author":"Vinnicombe","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0155","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1245\/s10434-014-3914-0","article-title":"Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy","volume":"21","author":"Weiss","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1075-122X.2006.00195.x","article-title":"Mammographic appearance of microcalcifications: can they change after neoadjuvant chemotherapy?","volume":"12","author":"Esserman","year":"2006","journal-title":"Breast J."},{"key":"10.1016\/j.ejrad.2019.06.017_bib0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clbc.2017.07.001","article-title":"Discrepancies between pathological tumor responses and estimations of complete response by magnetic resonance imaging after neoadjuvant chemotherapy differ by breast cancer subtype","volume":"18","author":"Namura","year":"2018","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ejrad.2019.06.017_bib0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiol.11110814","article-title":"Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging","volume":"261","author":"Chen","year":"2011","journal-title":"Radiology"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19302219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X19302219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:14:27Z","timestamp":1759994067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X19302219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S0720048X19302219"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.06.017","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2019.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}